News
Cagent Vascular, Inc., the exclusive developer of ... The study will be taking place at Columbia University Medical Center and Weill Cornell Medicine led by co-principal investigators Sahil ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results